<html>

<head>


<title>First India 8-K/A</title>



</head>

<body lang=EN-US>

&nbsp;<div align="center">
  <pre><font size="3" face="Times New Roman">SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549</font></pre>
</div>
<div align="center">
  <pre><font size="3" face="Times New Roman">-----------------</font></pre>
</div>
<div align="center">
  <pre><font size="3" face="Times New Roman">FORM 8-K</font></pre>
</div>
<div align="center">
  <pre><font size="3" face="Times New Roman">-----------------</font></pre>
</div>
<div align="center">
  <pre><font size="3" face="Times New Roman">CURRENT REPORT</font></pre>
</div>
<div align="center">
  <pre><font size="3" face="Times New Roman">PURSUANT TO SECTION 13 OR 15(D) OF
THE SECURITIES EXCHANGE ACT OF 1934</font></pre>
</div>
<div align="center">
  <pre><font size="3" face="Times New Roman">Date of Report (Date of earliest event reported): July 17, 2003</font></pre>
</div>
<div align="center">
  <pre><font size="3" face="Times New Roman">FIRST INDIA DIVERSIFIED HOLDINGS, INC.
(Exact Name of Registrant as Specified in Its Charter)</font></pre>
</div>
<div align="center">
  <pre><font size="3" face="Times New Roman">New York
(State or Other Jurisdiction of Incorporation)</font></pre>
</div>
<div align="center">
  <pre><font size="3" face="Times New Roman">0-30440
---------
(Commission File Number)</font></pre>
</div>
<div align="center">
  <pre><font size="3" face="Times New Roman">22-3537927
----------
(IRS Employer Identification No.)</font></pre>
</div>
<div align="center">
  <pre><font size="3" face="Times New Roman">Suite 40, 1010 University Avenue, San Diego, CA 92103
-------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)</font></pre>
</div>
<div align="center">
  <pre><font size="3" face="Times New Roman">(619) 615-055011
(Registrant's Telephone Number, Including Area Code)</font></pre>
</div>
<div align="center">
  <pre><font size="3" face="Times New Roman">(Former Name or Former Address, if Changed Since Last Report)</font></pre>
</div>
<pre>&nbsp;</pre><font face="Times New Roman">ITEM 1.&nbsp; CHANGE IN CONTROL OF REGISTRANT</font><p align="justify">
<font face="Times New Roman">On July 17, 2003, the controlling interest in the Registrant, totaling 51,000,000 shares of common stock, was sold to David R. Koos, a California resident, by Virtucon, Inc. for cash and a secured promissory note totaling $285,000. The note is secured by a security interest in the 51,000,000 shares comprising 83.6% of all of the issued and outstanding common stock of the Registrant.
</font></p>
<font face="Times New Roman">ITEM 5.&nbsp; OTHER EVENTS AND REGULATION FD DISCLOSURE</font><p align="justify">
<font face="Times New Roman">On July 17, 2003, the Company's new Board of Directors, comprised of David R. Koos and Marc Pilkington, adopted a resolution recommending that an Amendment to Registrant's Certificate of Incorporation be adopted by the shareholders at a meeting to be held on August 22, 2003, changing the name of Registrant to Cell Bio-Systems, Inc. and reverse splitting 1 for 4 Registrant's common stock. Also on July 17, 2003, the Registrant obtained an assignment from a related party allowing the Registrant to manufacture, market and sell disposable cannulas for use in liposuction.</font></p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<hr color="#000080">
<p>&nbsp;</p>



<p class=MsoNormal align="justify"><font face="Times New Roman">Marc
H. Pilkington is 47 years old and is a director, the President and CEO of the
Registrant.&nbsp; Mr. Pilkington was the President of Cell Bio-Systems, Inc., a
private Delaware corporation in the bio-medical device business, from 2002 to
2003 and was President of Tulip Medical, Inc., a bio-medical device
manufacturer, from 1998 to 2001.&nbsp; He was also an independent insurance agent
from 2001 to 2002. Mr. Pilkington is the co-inventor of the patented super-luer
connection system.&nbsp; This is one of the main bio-medical devices that Registrant
intends to refine.&nbsp; Mr. Pilkington graduated with a B.S. degree in Professional
Engineering from Embry Riddle Aeronautical University, Prescott, Arizona in
January, 1989.</font></p>

<p class=MsoNormal><font face="Times New Roman"><b>&nbsp;</b></font></p>

<p class=MsoNormal style='margin-left:.5in;text-align:justify;text-autospace:
none'><font face="Times New Roman">David R. Koos is
45 years old and is a Director, Chief Financial Officer and Corporate
Secretary. &nbsp;Mr. Koos has been involved with investment banking, venture capital
and investor relations for the past 20 years.&nbsp; He is and has been the founder and President of
Venture Bridge, Inc., a corporation engaged in the business of developing
biotechnology companies and is based in San Diego, California, from November,
2001 to Present, and was and has been a co-founder, Chief Financial Officer and
Corporate Secretary of Cell Bio-Systems, Inc., a Delaware corporation engaged
in the bio-medical device business from July, 2001 to the present.&nbsp; He also is
and has been the founder and managing director of Venture Bridge Advisors,
Inc., a venture capital and
compliance consulting firm in San Diego, California, from March, 2002 to the present. He is
also the founder
and has been managing director of Rosemont Venture Partners, Ltd., a consulting
business located in San Diego, California from July, 1999 to Present.&nbsp; He was a
Vice President, Investments, at Amerivet Securities, Inc., a licensed
securities broker dealer located in Santa Monica, California from November,
2000 to May, 2002. He was also self-employed as a business consultant in San
Diego, California from April, 1999 to July, 1999. He was a Vice President ,
Investments with Meridian Capital Group, Inc., a licensed securities broker
dealer in Newport Beach, California from June, 1998 to January, 1999.&nbsp; Mr. Koos graduated with a
M.A. in Sociology from the University of California (Riverside) in June, 1983.
He holds NASD Series 7 and 24 licenses. In June 2001, the NYSE found that while
he was at Everen Securities, Mr. Koos had engaged in excessive, unsuitable and
discretionary trading in a client's account and suspended him from association
with the NYSE and its affiliates for a period of 18 months.&nbsp; Rather than incurring
any further legal expenses, Mr. Koos agreed to accept the suspension even
though he maintains his innocence in any wrongdoing.</font></p>



<pre>&nbsp;</pre>
<hr color="#000080">



<pre>&nbsp;</pre>
<div align="center">
  <pre><font size="3" face="Times New Roman"> SIGNATURES</font></pre>
</div>
<pre>&nbsp;</pre><font face="Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf</font><font size="3" face="Times New Roman"> by the undersigned hereunto duly authorized.</font><pre>&nbsp;</pre>
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse: collapse" bordercolor="#111111" width="761" id="AutoNumber1">
  <tr>
    <td width="360">&nbsp;</td>
    <td width="398"><font size="3" face="Times New Roman">First India Diversified
    <br>
    Holdings, Inc.
<br>
    a New York corporation</font></td>
  </tr>
  <tr>
    <td width="360">&nbsp;</td>
    <td width="398">&nbsp;</td>
  </tr>
  <tr>
    <td width="360">&nbsp;</td>
    <td width="398">&nbsp;</td>
  </tr>
  <tr>
    <td width="360">&nbsp;</td>
    <td width="398"><font size="3" face="Times New Roman">&nbsp;By: Marc Pilkington</font></td>
  </tr>
  <tr>
    <td width="360">&nbsp;</td>
    <td width="398"><font size="3" face="Times New Roman">------------------------</font></td>
  </tr>
  <tr>
    <td width="360">&nbsp;</td>
    <td width="398"><font size="3" face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Marc Pilkington</font></td>
  </tr>
  <tr>
    <td width="360">&nbsp;</td>
    <td width="398"><font size="3" face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; President</font></td>
  </tr>
</table>
<pre>&nbsp;</pre><pre><font size="3" face="Times New Roman">DATED: July 17, 2003</font></pre>



</body>

</html>
[{"type": "8-K", "sequence": "1", "filename": "revised8k1.htm", "secsgml_size_bytes": 8176}]
{"company-data": {"conformed-name": "FIRST INDIA DIVERSIFIED HOLDINGS INC", "cik": "0001094735", "assigned-sic": "9995", "irs-number": "061551283", "state-of-incorporation": "NY", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-29193", "film-number": "03793331"}, "business-address": {"street1": "257-10 UNION TURNPIKE", "city": "FLORAL PARK", "state": "NY", "zip": "11004", "phone": "8882386400"}, "mail-address": {"street1": "257-10 UNION TURNPIKE", "city": "FLORAL PARK", "state": "NY", "zip": "11004"}}
First India 8-K/A
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-----------------
FORM 8-K
-----------------
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): July 17, 2003
FIRST INDIA DIVERSIFIED HOLDINGS, INC.
(Exact Name of Registrant as Specified in Its Charter)
New York
(State or Other Jurisdiction of Incorporation)
0-30440
---------
(Commission File Number)
22-3537927
----------
(IRS Employer Identification No.)
Suite 40, 1010 University Avenue, San Diego, CA 92103
-------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
(619) 615-055011
(Registrant's Telephone Number, Including Area Code)
(Former Name or Former Address, if Changed Since Last Report)
ITEM 1.  CHANGE IN CONTROL OF REGISTRANT
On July 17, 2003, the controlling interest in the Registrant, totaling 51,000,000 shares of common stock, was sold to David R. Koos, a California resident, by Virtucon, Inc. for cash and a secured promissory note totaling $285,000. The note is secured by a security interest in the 51,000,000 shares comprising 83.6% of all of the issued and outstanding common stock of the Registrant.
ITEM 5.  OTHER EVENTS AND REGULATION FD DISCLOSURE
On July 17, 2003, the Company's new Board of Directors, comprised of David R. Koos and Marc Pilkington, adopted a resolution recommending that an Amendment to Registrant's Certificate of Incorporation be adopted by the shareholders at a meeting to be held on August 22, 2003, changing the name of Registrant to Cell Bio-Systems, Inc. and reverse splitting 1 for 4 Registrant's common stock. Also on July 17, 2003, the Registrant obtained an assignment from a related party allowing the Registrant to manufacture, market and sell disposable cannulas for use in liposuction.
Marc
H. Pilkington is 47 years old and is a director, the President and CEO of the
Registrant.  Mr. Pilkington was the President of Cell Bio-Systems, Inc., a
private Delaware corporation in the bio-medical device business, from 2002 to
2003 and was President of Tulip Medical, Inc., a bio-medical device
manufacturer, from 1998 to 2001.  He was also an independent insurance agent
from 2001 to 2002. Mr. Pilkington is the co-inventor of the patented super-luer
connection system.  This is one of the main bio-medical devices that Registrant
intends to refine.  Mr. Pilkington graduated with a B.S. degree in Professional
Engineering from Embry Riddle Aeronautical University, Prescott, Arizona in
January, 1989.
David R. Koos is
45 years old and is a Director, Chief Financial Officer and Corporate
Secretary.  Mr. Koos has been involved with investment banking, venture capital
and investor relations for the past 20 years.  He is and has been the founder and President of
Venture Bridge, Inc., a corporation engaged in the business of developing
biotechnology companies and is based in San Diego, California, from November,
2001 to Present, and was and has been a co-founder, Chief Financial Officer and
Corporate Secretary of Cell Bio-Systems, Inc., a Delaware corporation engaged
in the bio-medical device business from July, 2001 to the present.  He also is
and has been the founder and managing director of Venture Bridge Advisors,
Inc., a venture capital and
compliance consulting firm in San Diego, California, from March, 2002 to the present. He is
also the founder
and has been managing director of Rosemont Venture Partners, Ltd., a consulting
business located in San Diego, California from July, 1999 to Present.  He was a
Vice President, Investments, at Amerivet Securities, Inc., a licensed
securities broker dealer located in Santa Monica, California from November,
2000 to May, 2002. He was also self-employed as a business consultant in San
Diego, California from April, 1999 to July, 1999. He was a Vice President ,
Investments with Meridian Capital Group, Inc., a licensed securities broker
dealer in Newport Beach, California from June, 1998 to January, 1999.  Mr. Koos graduated with a
M.A. in Sociology from the University of California (Riverside) in June, 1983.
He holds NASD Series 7 and 24 licenses. In June 2001, the NYSE found that while
he was at Everen Securities, Mr. Koos had engaged in excessive, unsuitable and
discretionary trading in a client's account and suspended him from association
with the NYSE and its affiliates for a period of 18 months.  Rather than incurring
any further legal expenses, Mr. Koos agreed to accept the suspension even
though he maintains his innocence in any wrongdoing.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
First India Diversified
Holdings, Inc.
a New York corporation
By: Marc Pilkington
------------------------
Marc Pilkington
President
DATED: July 17, 2003